NCT02124343

Brief Summary

Exercise is a cornerstone of pulmonary rehabilitation in the treatment of Chronic Obstructive Pulmonary Disease (COPD). Although researchers have shown numerous benefits with exercise in COPD patients, most studies have only looked at exercise tolerance and psychological outcomes following training. COPD is characterised by persistent inflammation that can cause progressive decline in lung function and multisystemic complications. This inflammation can be amplified in patients when they suffer acute exacerbations. There is a wellknown relationship between exercise, immune function and risk of infection. Exercise has also been shown to have an antiinflammatory effect when performed regularly. There is a lack of research looking into the inflammatory or immune response to exercise in patients with COPD. The exercise within this study will be individually tailored to patients with COPD based on their validated 6 minute walk test (6MWT) but the protocol will involve interval exercise that has been used previously. This type of exercise is considered most appropriate for research into mechanisms of benefit because it maintains the exercise training effects of other modalities (e.g. continuous low intensity aerobic exercise) while avoiding the occurrence of limitations to exercise in people with lung problems (e.g. dynamic hyperinflation). It also closely mirrors daily activity of someone with COPD. The investigators want to explore the effects of exercise specifically on immune function in 15 people COPD and compare any changes to 15 Controls. By better understanding the mechanisms of how exercise affects inflammation, the investigators could eventually design better Pulmonary Rehabilitation interventions, especially for those most at risk.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2014

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2014

Completed
1 month until next milestone

First Submitted

Initial submission to the registry

April 7, 2014

Completed
21 days until next milestone

First Posted

Study publicly available on registry

April 28, 2014

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2014

Completed
Last Updated

October 13, 2014

Status Verified

October 1, 2014

Enrollment Period

4 months

First QC Date

April 7, 2014

Last Update Submit

October 10, 2014

Conditions

Keywords

NeutrophilExerciseCOPDPulmonary Rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Neutrophil response to exercise

    The primary outcome measure for this study is to examine neutrophil responses to acute exercise, including changes in the counts and function of these cells in blood and sputa in order to compare any changes between COPD and age-gender matched controls.

    4 months

Secondary Outcomes (1)

  • Different health status and the responses on neutrophil function

    4 months

Other Outcomes (2)

  • Effect of inhaled steroids on neutrophil response following exercise

    4 months

  • Neutrophil response to exercise in past smokers versus non-smokers

    4 months

Study Arms (1)

Interval Exercise

EXPERIMENTAL

Subjects will undertake an interval exercise session (on a harnessed treadmill) (HP Cosmos Mercury 4.0, HP Cosmos Sports and Medical Gmbh, Nussdorf-Traustein,Germany) based on the average speed calculated from the 6 minute walk test (6MWT). Intervals are based on the work previously done by Mador et al., 2009 who used intervals of 150% (for 1 minute) followed by intervals of 75% (for 2 minutes) based on 80% average speed from the 6 minute walk test. This study repeated these intervals 7 times with a duration of 23 minutes in total for the exercise intervention with the 75% intervals at the start and at the end of the exercise session. No warm up was undertaken for this method as it was a walking exercise test and the risk of injury was minimised with use of the harnessed treadmill.

Other: Interval Exercise

Interventions

Interval Exercise

Eligibility Criteria

Age50 Years - 80 Years
Sexmale
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • COPD group - 15 Participants who have been diagnosed with any severity of COPD (according to BTS criteria, i.e. \>10 pack-year smoking history and post-bronchodilator spirometry FEV1/FVC ratio \<0.70 and FEV\<80%) and have completed at least 12 from 18 sessions of a pulmonary rehabilitation programme.
  • Age 50-80 years.
  • Current non-smoker.
  • Control group - 15 Participants who will act as Controls, without COPD or cardiovascular disease
  • Age 50-80 years (ideally of similar gender distribution)
  • Current non-smoker.
  • Spirometry: FEV1/FVC\>0.7 and FEV\>80% predicted

You may not qualify if:

  • Known asthma or allergic rhinitis or other respiratory disease (bronchiectasis, pulmonary fibrosis).
  • A change in any medications within 4 weeks or during the study.
  • Require domiciliary oxygen.
  • Acute exacerbation of COPD within 4 weeks of study entry.
  • Any infection or illness within 4 weeks of study entry.
  • Other active inflammatory conditions e.g. rheumatoid arthritis, cancer, unstable cardiac conditions.
  • Receiving oral steroids or other immunomodulating drugs.
  • Currently undergoing exercise training (including Pulmonary Rehabilitation).
  • Any previous cardiovascular contraindications to exercise (e.g. unstable angina).
  • Inability to complete the 6MWT due to physical or mental impairment.
  • Exhaled CO\>10ppm or smoked any cigarettes within 6 months.
  • Inability or unwillingness to sign informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Prince Philip Hospital

Llanelli, Carmarthenshire, SA14 8QF, United Kingdom

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic ObstructiveMotor Activity

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Alex R Jenkins, BSc (Hons)

    Aberystwyth University

    PRINCIPAL INVESTIGATOR
  • Keir E Lewis, MD

    Hywel Dda Health Board

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research Student

Study Record Dates

First Submitted

April 7, 2014

First Posted

April 28, 2014

Study Start

March 1, 2014

Primary Completion

July 1, 2014

Study Completion

July 1, 2014

Last Updated

October 13, 2014

Record last verified: 2014-10

Locations